On the use of list prices in drug pricing research

14 March 2019 - In the limitations section of this article, we discussed in detail that list prices do not capture ...

Read more →

Citizens ask - scientists answer: the IQWiG sets four new topics for HTA reports

23 January 2019 - Citizens, patients and medical experts: selection of topics with a sense of proportion ...

Read more →

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs

19 January 2019 - New policy environment demanding cheaper drugs adds pressure to innovate. ...

Read more →

Canadian R&D-to-sales ratio for brand-name drug companies less than half of 10% commitment

3 December 2018 - USMCA concessions latest hit to Canadian prescription drug costs. ...

Read more →

Request for proposals for PHARMAC and HRC research partnership 2019

8 October 2018 - PHARMAC and the Health Research Council of New Zealand request research proposals. ...

Read more →

Americans fund most of the world’s drug research. Here’s how Trump can end that.

9 August 2018 - President Donald Trump recently released an ambitious, 44-page plan to drive down prescription drug prices. The ...

Read more →

Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005

6 June 2018 - Well conducted clinical trials are widely regarded as the best source of evidence on the efficacy and ...

Read more →

Big pharma wants to invest more in Australian biotech says Greg Hunt

6 June 2018 - Big pharma is "looking at Australia as the next destination in the developed world, the emerging first-world ...

Read more →

Biosimilar education grant

23 April 2018 - A grant has been awarded to GBMA Education Limited to complement and extend the activities undertaken by ...

Read more →

Medical research caught in cross-fire of R&D tax overhaul

9 April 2018 - Industry commercialising medical research caught in cross-fire of R&D tax overhaul. ...

Read more →

Better support for patients with low survival cancers and diseases

9 March 2018 - The Australian Government is calling for applications from the country’s best and brightest researchers to help find ...

Read more →

Contribution of NIH funding to new drug approvals 2010–2016

12 February 2018 - This report shows that NIH funding contributed to published research associated with every one of the 210 ...

Read more →

Cancer research funding has an inherent bias that often excludes rare cancers, expert says

3 February 2018 - The biggest investor in cancer research in Australia needs to address an "inherent bias" in how ...

Read more →

Industry needs clarity to invest in Australia

31 January 2018 - Medicines Australia welcomes the release of the 2030 plan by Innovation and Science Australia but seeks ...

Read more →

Medical research? Congress cheers. Medical care? Congress brawls.

6 January 2018 - They cannot agree on subsidies for low-income people under the Affordable Care Act or even how ...

Read more →